Table: Phoenixbio -2022/23 group results

PhoenixBio

15/05/2023 07:30

May 15 (Reuters)- 
          Phoenixbio Co., Ltd. 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                   Year ended       Year ended       Year to       NEXT   
                Mar 31, 2023     Mar 31, 2022   Mar 31, 2024     YEAR     
                   LATEST          YEAR-AGO        COMPANY      COMPANY   
                   RESULTS         RESULTS        FORECAST    H1 FORECAST 
  Sales             2.12             1.32           2.04          1.01    
                 (+60.3 pct)                     (-4.0 pct)   (-10.9 pct) 
  Operating        508 mln       loss 167 mln      248 mln       95 mln   
                                                 (-51.1 pct)  (-73.9 pct) 
  Recurring        511 mln       loss 127 mln      250 mln       97 mln   
                                                 (-50.9 pct)  (-75.9 pct) 
  Net
  Net              493 mln       loss 387 mln      235 mln       91 mln   
                                                 (-52.2 pct)  (-74.5 pct) 
  EPS            145.23 yen    loss 117.50 yen    69.45 yen    26.84 yen  
  EPS Diluted     97.29 yen                                               
  Ann Div            NIL             NIL             NIL                  
  -Q2 Div            NIL             NIL             NIL                  
  -Q4 Div            NIL             NIL             NIL                  
  
  NOTE - Phoenixbio Co., Ltd..
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=6190.T